$1.030
-0.713 (-69.25%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
類似チャート分析による FEED の予測・予想
Alphio's FEED stock price prediction model matches the current ENvue Medical Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.01 (-1.49%). The 1-week path is $0.98 (-4.72%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
ENvue Medical Inc 株は買うべき?
ENvue Medical, Inc. (FEED) is not a good buy right now due to its extremely low price of $1.03, a staggering year-to-date change of -96.50%, and an RSI of 7.252 indicating oversold conditions. The company has also reported a gross margin of -111.30% in Q2 2026, highlighting severe profitability issues. The main risk is its recent performance, with a 5-day change of -75.93%, indicating continued downward pressure on the stock.
FEED の株価は Tuesday に $1.03 で引け、その前に下落 -69.25%
ENvue Medical Inc (FEED) last closed at $1.03, losing -69.25%. These facts feed the 1-day and 1-week FEED price prediction above.
予想の要因
ENvue Medical Inc(FEED)の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Similar patterns
Bearish
SMA 20
Bearish
SMA 200
Bearish
類似チャートパターン
直近の値動きが FEED に最も近い銘柄を、類似度順に表示します。
FEED の季節性分析
関連記事
- Money Market Funds vs High-Yield Savings vs T-Bills: Where to Park Cash as the Fed HikesMoney market funds, high-yield savings or T-bills? Compare November 2026 yields, taxes, FDIC rules and liquidity as the Fed hikes, and build a smart cash plan.
- Homebuilder Stocks With Mortgage Rates Above 7%: An Investor's Guide for Late 2026Homebuilder stocks face 7% mortgage rates and a 16-year low in home sales. See what D.R. Horton, Lennar and Pulte earnings show and how to invest in 2026.
- Bitcoin Bear Market 2026: Why BTC Fell Below $70K and How Investors Can Manage Crypto RiskBitcoin is about 45% below its $126K peak as Fed hikes, 5% yields and ETF outflows bite. See how the 2026 bear market compares and how to manage crypto risk.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。